Most Emailed Articles

1 2 3 4 5

All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up

Anderegg, Nanina; Johnson, Leigh F.; Zaniewski, Elizabeth; More

AIDS. 31:S31-S40, April 2017.

An advanced BLT-humanized mouse model for extended HIV-1 cure studies

Lavender, Kerry J.; Pace, Craig; Sutter, Kathrin; More

AIDS. 32(1):1-10, January 2, 2018.

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

Siefried, Krista J.; Mao, Limin; Cysique, Lucette A.; More

AIDS. 32(1):35-48, January 2, 2018.

‘I will choose when to test, where I want to test’: investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe

Indravudh, Pitchaya P.; Sibanda, Euphemia L.; d’Elbée, Marc; More

AIDS. 31:S203-S212, July 1st, 2017.

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases

Engelhard, Esther A.N.; Smit, Colette; van Dijk, Peter R.; More

AIDS. 32(1):103-112, January 2, 2018.

Abacavir use and risk of recurrent myocardial infarction

Sabin, Caroline A.; Ryom, Lene; d’Arminio Monforte, Antonella; More

AIDS. 32(1):79-88, January 2, 2018.

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

Mouton, Yves; Alfandari, Serge; Valette, Michel; More

AIDS. 11(12):F101-F105, October 11th, 1997.

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

Konopnicki, Deborah; Mocroft, Amanda; de Wit, S; More

AIDS. 19(6):593-601, April 8th, 2005.

HIV type 2 epidemic in Spain: challenges and missing opportunities

de Mendoza, Carmen; Cabezas, Teresa; Caballero, Estrella; More

AIDS. 31(10):1353-1364, June 19th, 2017.

1 2 3 4 5